(Q72009432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Release of 5-ASA from Pentasa in patients with Crohn's disease of the small intestine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Release of 5‐ASA from Pentasa in patients with Crohn's disease of the small intestine (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

21 July 2024

1 reference

J. Larouche

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

J. Morais

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

M. Picard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

C. Lambert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

J. Spénard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

H. Landriault

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

G. Kennedy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

P. Poitras

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654894

21 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7654894

21 July 2024

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.1995.tb00387.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.1995.tb00387.x

21 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

Alimentary Pharmacology & Therapeutics

21 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

315-320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

Localization of drug release sites from an oral sustained-release formulation of 5-ASA (Pentasa) in the gastrointestinal tract using gamma scintigraphy

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

Assay of 5-aminosalicylate and its acetylated metabolite in biological fluids by high-performance liquid chromatography on dynamically modified silica

21 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

High-performance liquid chromatographic assay of 5-aminosalicylic acid (5-ASA) and its metabolites N-beta-D-glucopyranosyl-5-ASA, N-acetyl-5-ASA, N-formyl-5-ASA and N-butyryl-5-ASA in biological fluids

21 July 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

Disposition of 5-aminosalicylic acid from 5-aminosalicylic acid-delivering drugs during accelerated intestinal transit in healthy volunteers

21 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease

21 July 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea

21 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

21 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.1995.TB00387.X

21 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654894%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference